series-c-plus
Stage
1
Investors
About
Mumac Ltd develops patented digital screening instruments, including RapiDA, designed for early detection of Age-Related Macular Degeneration (AMD) through a fast, affordable, and clinically validated dark adaptation testing process.
Explore Mumac Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.